MedTrace Logo

Transradial and Transfemoral Coronary Angiography by EXPERienced operaTors

NCT01794325 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2014-09-17

No results posted yet for this study

Summary

Transradial approach (TRA) reduces vascular complications and access related-bleeding compared to transfemoral approach (TFA). However, this technique has been related to higher radiation exposure during coronary angiography and percutaneous coronary intervention. Previous studies have shown that TRA demands a long learning curve, and procedure success rate increases with operator's experience. Our hypothesis is that the higher radiation exposure during TRA is not a technique issue, but due to operator's expertise.

The aim of this study is to evaluate whether experienced operators with either TRA or TFA can perform diagnostic coronary angiography with similar radiation exposure.

Conditions

Interventions

OTHER

Trans-radial

Coronary angiography performed through trans-radial access

OTHER

Trans-femoral

Coronary angiography performed through trans-femoral access

Sponsors & Collaborators

  • Hospital Ernesto Dornelles

    collaborator OTHER

  • Instituto de Cardiologia do Rio Grande do Sul

    lead OTHER

Principal Investigators

  • Cristiano O Cardoso, MD, MSc · Instituto de Cardiologia do Rio Grande do Sul

  • Luis M Yordi, MD · Hospital Ernesto Dornelles

  • Claudio V Moraes, MD · Insituto de Cardiologia do Rio Grande do Sul

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-01-31
Completion
2014-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01794325 on ClinicalTrials.gov